ARDX
Price
$7.38
Change
-$0.35 (-4.52%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
1.88B
35 days until earnings call
Intraday BUY SELL Signals
MAIA
Price
$2.06
Change
+$0.07 (+3.50%)
Updated
Feb 4, 02:59 PM (EDT)
Capitalization
74.06M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARDX vs MAIA

Header iconARDX vs MAIA Comparison
Open Charts ARDX vs MAIABanner chart's image
Ardelyx
Price$7.38
Change-$0.35 (-4.52%)
Volume$29.17K
Capitalization1.88B
MAIA Biotechnology
Price$2.06
Change+$0.07 (+3.50%)
Volume$2.5K
Capitalization74.06M
ARDX vs MAIA Comparison Chart in %
View a ticker or compare two or three
VS
ARDX vs. MAIA commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Hold and MAIA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ARDX: $7.74 vs. MAIA: $2.00)
Brand notoriety: ARDX and MAIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 71% vs. MAIA: 38%
Market capitalization -- ARDX: $1.88B vs. MAIA: $74.06M
ARDX [@Biotechnology] is valued at $1.88B. MAIA’s [@Biotechnology] market capitalization is $74.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileMAIA’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • MAIA’s FA Score: 0 green, 5 red.
According to our system of comparison, ARDX is a better buy in the long-term than MAIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 2 TA indicator(s) are bullish while MAIA’s TA Score has 3 bullish TA indicator(s).

  • ARDX’s TA Score: 2 bullish, 6 bearish.
  • MAIA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MAIA is a better buy in the short-term than ARDX.

Price Growth

ARDX (@Biotechnology) experienced а -1.90% price change this week, while MAIA (@Biotechnology) price change was -32.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

ARDX is expected to report earnings on Mar 11, 2026.

MAIA is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARDX($1.88B) has a higher market cap than MAIA($74.1M). ARDX YTD gains are higher at: 32.762 vs. MAIA (30.719). MAIA has higher annual earnings (EBITDA): -22.34M vs. ARDX (-26.22M). ARDX has more cash in the bank: 243M vs. MAIA (10.9M). ARDX has higher revenues than MAIA: ARDX (398M) vs MAIA (0).
ARDXMAIAARDX / MAIA
Capitalization1.88B74.1M2,538%
EBITDA-26.22M-22.34M117%
Gain YTD32.76230.719107%
P/E RatioN/AN/A-
Revenue398M0-
Total Cash243M10.9M2,229%
Total Debt208MN/A-
FUNDAMENTALS RATINGS
ARDX: Fundamental Ratings
ARDX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
46
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARDXMAIA
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
Bullish Trend 9 days ago
89%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ARDX
Daily Signal:
Gain/Loss:
MAIA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDOBX10.48N/A
N/A
Morgan Stanley Developing Opportunity C
MAIIX20.46-0.01
-0.05%
iShares MSCI EAFE Intl Idx Instl
SEVSX40.30-0.06
-0.15%
NAA SMid Cap Value C
AIVBX20.89-0.18
-0.85%
American Funds International Vntg A
BUFIX24.90-0.24
-0.95%
Buffalo International

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
-0.64%
VCYT - ARDX
45%
Loosely correlated
-1.10%
PCVX - ARDX
35%
Loosely correlated
-2.91%
RNAC - ARDX
35%
Loosely correlated
+2.06%
CLRB - ARDX
31%
Poorly correlated
-0.95%
DOMH - ARDX
31%
Poorly correlated
+1.02%
More

MAIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MAIA has been loosely correlated with CRVS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MAIA jumps, then CRVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
+3.09%
CRVS - MAIA
36%
Loosely correlated
+1.72%
ACRS - MAIA
31%
Poorly correlated
-3.88%
ATOS - MAIA
30%
Poorly correlated
-1.07%
ARDX - MAIA
29%
Poorly correlated
-0.64%
AVBP - MAIA
28%
Poorly correlated
-0.15%
More